Increased FluoroDeoxyGlucose (FDG) Avidity Following COVID-19 Vaccination

Mo'ath Nassar; Ayman Soubani

doi:10.3390/arm90050047

Increased FluoroDeoxyGlucose (FDG) Avidity Following COVID-19 Vaccination

Adv Respir Med. 2022 Aug 24;90(5):376-377. doi: 10.3390/arm90050047.

Authors

Mo'ath Nassar¹, Ayman Soubani¹

Affiliation

¹ Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA.

Abstract

A 65-year-old woman presented to the Pulmonary Clinic for evaluation after Positron Emission Tomography/Computed Tomography (PET/CT), which was obtained for assessment of a 12 mm right middle lobe solitary pulmonary nodule [...].

Keywords: COVID-19 vaccination; axillary lymphadenopathy; complications.

Publication types

Case Reports
Letter

MeSH terms

Aged
COVID-19 Vaccines
COVID-19* / prevention & control
Female
Fluorodeoxyglucose F18*
Humans
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography / methods
Vaccination

Substances

COVID-19 Vaccines
Fluorodeoxyglucose F18

Grants and funding

This manuscript received no external funding.